To improve the Nigerian Healthcare System, Carna Health investments Limited (Carna), a Nigerian healthcare investment vehicle created by Cedar Advisory Partners Limited (“Cedar”), said it is providing long-term equity funding and enabling the growth of facilities/institutions with high-growth potential across the Nigerian healthcare value chain.
In a disclosure made recently by the company, it explained that the investments made by Carna cuts across all strata of the health sector.
According to Carna’s Managing Director, Afolabi Adetola, the company is building the most efficient, standard and affordable healthcare ecosystem in Nigeria. Within the last 10 years, he said it had advised major hospitals and healthcare operators in Nigeria in various capacities through its parent company, Cedar
“As advisers, operators, and users of healthcare in Nigeria, we understand first- hand the challenges with maintaining an efficient healthcare space and are driven by the need for increased capacity for the delivery of quality healthcare in Nigeria as well as the opportunities within the industry and its practice,” Adetola said.
The MD added that the company has morphed into a healthcare investing platform. “Given that we acknowledge that the issues are multi- faceted, our approach is also multifaceted.”
Read Also: Pharmacists’ group calls for liberalised appointments in health sector
According to the Lagos based company, it is out to provide long- term equity funding and enable the growth of facilities/ institutions with high growth potential across the healthcare value chain including but not limited to primary, secondary and tertiary hospitals, diagnostic and clinical laboratories, health insurance firms, and pharmacies.
Caran said it has made investments in laboratory and imaging diagnostic, health insurance firm and health management firms.
“We understand that investing in healthcare in Nigeria is a long-term business and requires patient capital. While we acknowledge the role of the government and public funding, the private investor who will drive efficiency and global best practices over the foreseeable future can unlock immense opportunities,” it said.
With an approach that is centered on ecosystem building to enable resourcesharing, standardization and cost-efficiency, the core strategy of Caran is the management of a network of hospitals and day clinics.
With this model, the company said human and material resources including doctors, nurses, medical and non- medical practitioners, technology and systems, clinical and nonclinical administration can be centralized and accessed by all facilities within the network.
“Our day clinics under the brand name, Carnamed, are 12-hour outpatient facilities with the mandate to offer quick, affordable and quality primary healthcare services to lower-middle income and middle-income segments of the population in most densely populated areas.
Its primary services, according to Carna include general consultation, vaccination, urgent care, family planning, and other health packages while fitted with laboratories and pharmacies. In select locations, Carnamed clinics will also offer dentistry, optometry and dermatology services.
“The hospitals we are interested in are purpose built practices in urban areas with a certain bed capacity. Our current investments include a leading laboratory and imaging diagnostic, a national health insurance firm and a health management firm,” Adetola said.
